Close Menu

The first Open Science Summit will be taking place in late July, from the 29th to the 31st in Berkeley, California. This event is "an attempt to gather all stakeholders who want to liberate our scientific and technological commons to enable an new era of decentralized, distributed innovation to solve humanity's greatest challenges," the conference description says. Among the topics on the agenda include synthetic biology, DIY science, and science publishing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.